---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-190764"
form_type: "8-K"
ticker: null
cik: "0001805387"
company_name: "Cerevel Therapeutics Holdings, Inc."
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T13:56:42.412682+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# AbbVie completes $45/share acquisition of Cerevel; Cerevel becomes wholly owned subsidiary

## Summary
- Cerevel stockholders received $45.00 per share in cash for each share; total consideration not disclosed.
- All 12 board members resigned; Scott Reents (from Merger Sub) becomes sole director.
- Cerevel shares ceased trading on Nasdaq effective August 1, 2024; deregistration to follow.
- AbbVie reaffirms FY2024 adjusted EPS guidance of $10.71-$10.91, including $0.19 dilutive impact from deal.
- Key assets: emraclidine (schizophrenia, Phase 2 registration-enabling), tavapadon (Parkinson's, Phase 3 met primary endpoint).

## SEC filing metadata
- accession: 0001193125-24-190764
- form_type: 8-K
- cik: 0001805387
- company_name: Cerevel Therapeutics Holdings, Inc.
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/d814318d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-190764
- JSON: https://secwatch.observer/filing/0001193125-24-190764.json
- Plain text: https://secwatch.observer/filing/0001193125-24-190764.txt

## Key facts
- Executive change
  Douglas Giordano resigned as Director at Cerevel Therapeutics Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm
- Executive change
  Adam Koppel, M.D., Ph.D. resigned as Director at Cerevel Therapeutics Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm
- Executive change
  Marijn Dekkers, Ph.D. resigned as Director at Cerevel Therapeutics Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm
- Executive change
  Deval Patrick resigned as Director at Cerevel Therapeutics Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm
- Executive change
  Tony Coles, M.D. resigned as Director at Cerevel Therapeutics Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm
- Executive change
  Scott T. Reents was appointed as Director at Cerevel Therapeutics Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: Scott T. Reents, the sole director of Merger Sub immediately prior to the Effective Time, became the sole director of Cerevel.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm
- Executive change
  Ruth McKernan, Ph.D. resigned as Director at Cerevel Therapeutics Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm
- Executive change
  Gabrielle Sulzberger resigned as Director at Cerevel Therapeutics Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm
- Executive change
  Suneet Varma resigned as Director at Cerevel Therapeutics Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm
- Executive change
  Ron Renaud resigned as Director at Cerevel Therapeutics Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm
- Executive change
  Norbert Riedel, Ph.D. resigned as Director at Cerevel Therapeutics Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm
- Executive change
  Deborah Baron resigned as Director at Cerevel Therapeutics Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm
- Executive change
  Chris Gordon resigned as Director at Cerevel Therapeutics Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.